LINC02389/miR-7-5p Regulated Cisplatin Resistance of Non-Small-Cell Lung Cancer via Promoting Oxidative Stress

Figure 2

(a) LINC02389 expression in A549 and HCC827 cell lines compared with MRC5. (b) Knockdown of LINC02389 in A549. (c) Knockdown of LINC02389 in HCC827. (d) CCK-8 results for LINC02389 knockdown in A549. (e) CCK-8 results for LINC02389 knockdown in HCC827. (f) Transwell assay to detect the effect of LINC02389 knockdown on migration ability in A549. (g) Transwell assay to detect the effect of LINC02389 knockdown on migration ability in HCC827. (h) Caspase 3/7 assay to evaluate the effect of LINC02389 knockdown on apoptosis rate in A549. (i) Caspase 3/7 assay to evaluate the effect of LINC02389 knockdown on apoptosis rate in HCC827.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)